16-Nov-2012 - Eurofins Genomics Germany GmbH

GATC Biotech is a partner in decoding the genome of the pathogen Colletotrichum

Detailed information about the transcriptome help to understand the disease mechanism of a fungal pathogen

In collaboration with the Max Planck Institute (MPI) for Plant Breeding Research in Cologne GATC Biotech AG has decoded the genome of the fungal pathogen Colletotrichum graminicola. The recently published results show that gene expression plays a decisive role in plant disease. With this knowledge the international project aims to improve plant protection from this pest.

Since 2008 an international team of scientists has been involved in the project. Throughout the process, genome and transcriptome of Colletotrichum graminicola have been decoded and analyzed. For the first time in-depth knowledge of the transcriptome has provided information about timing and location of the expression of genes critical to the infection process.

The study revealed that the life of the pathogen determines gene features and gene expression. “The high quality of the sequencing has allowed us to obtain these remarkable insights“, tells Dr. Richard O’Connell, Head of the project. These insights are said to be of fundamental importance for future rational plant breeding und the research into finding methods for reducing the effects of this pathogen.

“The extensive use of Next Gen sequencing technologies, at that time still early in their development, and only a minimum of the standard Sanger technology made this project a challenge and very rewarding to complete“, states Dr. Christopher Bauser, Senior Scientific Project Specialist of GATC Biotech.

The challenge of sequencing has been the broad usage of different DNA preparation methods and sequencing technologies. The raw data have been assembled de novo without comparison to a similar reference genome. 

Facts, background information, dossiers
  • GATC Biotech
  • genomes
  • Colletotrichum graminicola
More about Eurofins
  • News

    Eurofins scientific acquires two North American companies

    By acquiring EnvironeX Group Inc. in Canada and TestAmerica in the USA Eurofins expands its testing capabilities in the North American market. EnvironeX Group Inc. - bioanalytical testing in Canada Founded in 2005 by Marc Hamilton and supported by PCP since 2015, EnvironeX is a leading prov ... more

    Eurofins acquires German pharma quality service company

    Eurofins Scientific announces that it has signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (“PHAST”), one of Europe’s leading service providers in the field of pharmaceutical products quality. The transaction is expected to close in the ... more

    Eurofins expands its footprint in Asia with the acquisition of Lab Frontier in South Korea

    Eurofins Scientific (EUFI.PA) announces that it has successfully closed the transaction to acquire Lab Frontier Co., Ltd., which provides a broad suite of food, environment and cosmetics testing services in South Korea. Lab Frontier, an affiliate company of Young In Group (YIG), will furthe ... more

  • Companies

    Eurofins Genomics Germany GmbH

    FAST. We produce and analyze DNA & RNA Eurofins Genomics, a member of the Eurofins Group with facilities in Europe, USA and Asia, is an internationally leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services for pharma, diagnosti ... more

    Eurofins Medigenomix GmbH

    more

    Eurofins Genomics B.V.

    Eurofins Scientific is a life sciences company operating laboratories in 30 countries to provide a comprehensive range of analytical testing services drawing on the latest developments in biotechnology. The Group specialises in delivering analytical testing and advisory services to clients ... more

More about MPI für Pflanzenzüchtungsforschung